Bendamustine Eugia 2.5 mg/ml inj. sol. (pwdr., conc.) i.v. vial Belgija - engleski - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

bendamustine eugia 2.5 mg/ml inj. sol. (pwdr., conc.) i.v. vial

eugia pharma (malta) ltd. - bendamustine hydrochloride monohydrate 26,14 mg - eq. bendamustine hydrochloride 25 mg - powder for concentrate for solution for infusion - bendamustine

Bendamustine Eugia 2.5 mg/ml inj. sol. (pwdr., conc.) i.v. vial Belgija - engleski - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

bendamustine eugia 2.5 mg/ml inj. sol. (pwdr., conc.) i.v. vial

eugia pharma (malta) ltd. - bendamustine hydrochloride monohydrate 26,14 mg - eq. bendamustine hydrochloride 25 mg - powder for concentrate for solution for infusion - bendamustine

BENDAMUSTINE S.K. 100 MG Izrael - engleski - Ministry of Health

bendamustine s.k. 100 mg

k.s.kim international (sk- pharma) ltd., israel - bendamustine as hydrochloride monohydrate - powder for concentrate for solution for infusion - bendamustine as hydrochloride monohydrate 100 mg/vial - bendamustine - first-line of chronic lymphocytic leukaemia (binet stage b or c) in patients for whom fludarabine combination chemotheraphy is not appropiate. indolent non-hodgkin’s lymphomas as monotheraphy in patients, who have progressed during or within 6 months following treatment with rituximab or a rituximab containing regimen. follicular non-hodgkin’s lymphoma as first line treatment in combination with rituximab.

BENDAMUSTINE S.K. 25 MG Izrael - engleski - Ministry of Health

bendamustine s.k. 25 mg

k.s.kim international (sk- pharma) ltd., israel - bendamustine as hydrochloride monohydrate - powder for concentrate for solution for infusion - bendamustine as hydrochloride monohydrate 25 mg/vial - bendamustine - first-line of chronic lymphocytic leukaemia (binet stage b or c) in patients for whom fludarabine combination chemotheraphy is not appropiate. indolent non-hodgkin’s lymphomas as monotheraphy in patients, who have progressed during or within 6 months following treatment with rituximab or a rituximab containing regimen. follicular non-hodgkin’s lymphoma as first line treatment in combination with rituximab.

Pfizer Bendamustine Concentrated Injection Novi Zeland - engleski - Medsafe (Medicines Safety Authority)

pfizer bendamustine concentrated injection

pfizer new zealand limited - bendamustine hydrochloride monohydrate 104.6mg equivalent to 100 mg bendamustine hydrochloride - concentrate for injection - 100 mg/4ml - active: bendamustine hydrochloride monohydrate 104.6mg equivalent to 100 mg bendamustine hydrochloride excipient: butylated hydroxyanisole ethanol macrogol 400 sodium hydroxide water for injection - first line treatment of chronic lymphocytic leukaemia (binet stage b or c).

Pfizer Bendamustine Concentrated Injection Novi Zeland - engleski - Medsafe (Medicines Safety Authority)

pfizer bendamustine concentrated injection

pfizer new zealand limited - bendamustine hydrochloride monohydrate 26.1mg equivalent to 25 mg bendamustine hydrochloride - concentrate for injection - 25 mg/ml - active: bendamustine hydrochloride monohydrate 26.1mg equivalent to 25 mg bendamustine hydrochloride excipient: butylated hydroxyanisole ethanol macrogol 400 sodium hydroxide water for injection - first line treatment of chronic lymphocytic leukaemia (binet stage b or c).

Bendamustine Accord 25 mg/ml inf. sol. (conc.) i.v. vial Belgija - engleski - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

bendamustine accord 25 mg/ml inf. sol. (conc.) i.v. vial

accord healthcare b.v. - bendamustine hydrochloride monohydrate 26,14 mg/ml - eq. bendamustine hydrochloride 25 mg/ml - concentrate for solution for infusion - bendamustine

BENDAMUSTINE HCL Irska - engleski - HPRA (Health Products Regulatory Authority)

bendamustine hcl

fresenius kabi oncology plc - bendamustine hydrochloride - pdr/conc/soln for infus - 25 milligram - bendamustine